This variability is believed to be due to differences in tumour size, cavernous sinus invasion, the presence of an ectopic tumour, perioperative glucocorticoid use, corticosteroid-binding protein (transcortin) level, and the extent of tumour resection. Here, SERPINA6 is linked to neoplasm.